Table 2.
Characteristics of the index tumor in all 235 patients with multiple of unifocal breast carcinoma.
| Variable | No. of Patients (%) | |
|---|---|---|
| Gender | Female | 229 (97.45%) |
| Male | 6 (2.55%) | |
| Laterality | Left sided | 139 (59.15%) |
| Right sided | 78 (33.19%) | |
| Bilateral | 4 (1.70%) | |
| Unknown | 14 (5.96%) | |
| pTNM | IA | 46 (19.57%) |
| IIA | 61 (25.96%) | |
| IIB | 41 (17.45%) | |
| IIIA | 10 (4.26%) | |
| IIIB | 19 (8.09%) | |
| IIIC | 4 (1.7%) | |
| IV | 33 (14.04%) | |
| Unknown | 21 (8.94%) | |
| Grade of differentiation | G1 | 38 (16.17%) |
| G2 | 124 (52.77%) | |
| G3 | 59 (25.11%) | |
| Unknown | 14 (5.96%) | |
| Nodal metastasis | pN0 | 132 (56.17%) |
| pN1 | 65 (17.66%) | |
| pN2 | 12 (5.11%) | |
| pN3 | 5 (2.13%) | |
| Unknown | 21 (8.93%) | |
| ER status | positive | 150 (63.83%) |
| negative | 45 (19.15%) | |
| Unknown | 40 (17.02%) | |
| PR status | positive | 153 (65.11%) |
| negative | 42 (17.87%) | |
| Unknown | 40 (17.02%) | |
| HER2 | 0 | 131 (55.74%) |
| 1+ | 28 (11.91%) | |
| 2+ | 14 (5.96%) | |
| 3+ | 13 (5.53%) | |
| Unknown | 49 (20.85%) | |
| P53 | positive | 26 (11.06%) |
| negative | 52 (22.13%) | |
| Unknown | 157 (66.80%) | |
P = by histopathological examination; pTNM = Pathological Tumor-Node-Metastasis; ER = estrogen receptor, PR = progesterone receptor, HER2 = Human Epidermal Growth Factor Receptor 2.